<DOC>
	<DOCNO>NCT02022683</DOCNO>
	<brief_summary>To compare clinical outcome Endoscopic Lung Volume Reduction use Pulmonx Zephyr Endobronchial Valve ( EBV ) vs. Standard Care ( SoC ) treatment heterogeneous emphysema patient control trial design setting .</brief_summary>
	<brief_title>To Improve Lung Function Symptoms Emphysema Patients Using Zephyr EBV</brief_title>
	<detailed_description />
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Heterogeneous emphysema 15 % pred &lt; = FEV1 &lt; = 45 % pred TLC &gt; 100 % RV &gt; = 180 % 150 &lt; = 6MWT &lt; = 450 No collateral ventilation Contraindication bronchoscopy Active pulmonary infection History 2 exacerbation hospitalization past 12 month Known pulmonary hypertension Prior LVR LVRS procedure Pregnant lactate woman Hypercapnia Current diagnosis asthma &gt; 25 mg Prednisolon / day CV target lobe inconclusive Chartis assessment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Endoscopic lung volume reduction</keyword>
	<keyword>Endobronchial valve</keyword>
</DOC>